457 related articles for article (PubMed ID: 11419839)
21. Hepatocellular carcinoma treated with chemoembolization: assessment with contrast-enhanced doppler ultrasonography.
Catalano O; Esposito M; Lobianco R; Cusati B; Altei F; Siani A
Cardiovasc Intervent Radiol; 1999; 22(6):486-92. PubMed ID: 10556408
[TBL] [Abstract][Full Text] [Related]
22. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
[TBL] [Abstract][Full Text] [Related]
23. [Role of color Doppler ultrasonography with contrast media in the monitoring of hepatocarcinoma after intralesional treatment].
Pennisi F; Farina R; Ponzio R; Fragione D; Lombardo R; Azzarello G; Puleo S
Radiol Med; 1999 Mar; 97(3):144-7. PubMed ID: 10363055
[TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
27. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound.
Koda M; Matsunaga Y; Ueki M; Maeda Y; Mimura K; Okamoto K; Hosho K; Murawaki Y
Eur Radiol; 2004 Jun; 14(6):1100-8. PubMed ID: 14676975
[TBL] [Abstract][Full Text] [Related]
28. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
[TBL] [Abstract][Full Text] [Related]
29. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist.
Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
J Ultrasound Med; 2002 Sep; 21(9):1015-22. PubMed ID: 12216749
[TBL] [Abstract][Full Text] [Related]
31. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
[TBL] [Abstract][Full Text] [Related]
33. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors.
Hotta N; Tagaya T; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
Clin Imaging; 2005; 29(1):34-41. PubMed ID: 15859016
[TBL] [Abstract][Full Text] [Related]
34. [Enhanced color flow findings in small hepatocellular carcinoma].
Maruyama H; Matsutani S; Ebara M; Saisho H
Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
[TBL] [Abstract][Full Text] [Related]
35. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
Jung EM; Clevert DA; Rupp N
Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography.
Choi D; Lim HK; Lee WJ; Kim SH; Kim MJ; Kim SK; Jang KM; Lee JY; Lim JH
Korean J Radiol; 2004; 5(3):185-98. PubMed ID: 15467416
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography.
Gaiani S; Celli N; Piscaglia F; Cecilioni L; Losinno F; Giangregorio F; Mancini M; Pini P; Fornari F; Bolondi L
J Hepatol; 2004 Sep; 41(3):421-6. PubMed ID: 15336445
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
Khong PL; Chau MT; Fan ST; Leong LL
Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
[TBL] [Abstract][Full Text] [Related]
39. Is Doppler/Dopplex ultrasonography reliable in the assessment of percutaneous ablative therapies of hepatocellular carcinoma: a prospective cross-sectional study.
Darweesh SK; El-Kady NM; Abdel-Haleem H; Amer AR; Maher RM
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e183-e190. PubMed ID: 33208684
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma: contrast enhancement with Levovist.
Choi BI; Kim AY; Lee JY; Kim KW; Lee KH; Kim TK; Han JK
J Ultrasound Med; 2002 Jan; 21(1):77-84. PubMed ID: 11794406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
